These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7776301)

  • 1. Off-label drug prescribing on a state university obstetric service.
    Rayburn WF; Turnbull GL
    J Reprod Med; 1995 Mar; 40(3):186-8. PubMed ID: 7776301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A physician's prerogative to prescribe drugs for off-label uses during pregnancy.
    Rayburn WF
    Obstet Gynecol; 1993 Jun; 81(6):1052-5. PubMed ID: 8497349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment off-label prescribing in Dermatology].
    Picard D; Carvalho P; Bonnavia C; Louin L; Josset V; Lauret P; Joly P;
    Ann Dermatol Venereol; 2003 May; 130(5):507-10. PubMed ID: 12843825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Off-label' drug use: an FDA regulatory term, not a negative implication of its medical use.
    Meadows WA; Hollowell BD
    Int J Impot Res; 2008; 20(2):135-44. PubMed ID: 18004389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Off-label prescribing].
    Blondon K; Desmeules J; Vogt-Ferrier N; Besson M; Kondo-Oestreicher M; Dayer P
    Rev Med Suisse; 2008 Jul; 4(165):1661-5. PubMed ID: 18767292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Satisfaction with pharmacotherapy for approved and off-label indications--a Delphi study.
    Kos M; Wertheimer AI; Mrhar A
    Ann Pharmacother; 2005 Apr; 39(4):649-54. PubMed ID: 15755789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Off-label prescribing during pregnancy in the UK: an analysis of 18,000 prescriptions in Liverpool Women's Hospital.
    Herring C; McManus A; Weeks A
    Int J Pharm Pract; 2010 Aug; 18(4):226-9. PubMed ID: 20636674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Off-label prescribing among office-based physicians.
    Radley DC; Finkelstein SN; Stafford RS
    Arch Intern Med; 2006 May; 166(9):1021-6. PubMed ID: 16682577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Off-label prescriptions in dermatology].
    Joly P
    Ann Dermatol Venereol; 2003 May; 130(5):505-6. PubMed ID: 12843824
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug, patient, and physician characteristics associated with off-label prescribing in primary care.
    Eguale T; Buckeridge DL; Winslade NE; Benedetti A; Hanley JA; Tamblyn R
    Arch Intern Med; 2012 May; 172(10):781-8. PubMed ID: 22507695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive outcomes through the appropriate use of off-label prescribing.
    Bright JL
    Arch Intern Med; 2006 Dec 11-25; 166(22):2554-5; author reply 2555. PubMed ID: 17159026
    [No Abstract]   [Full Text] [Related]  

  • 12. A survey of off-label prescribing for inpatients with mild intellectual disability and mental illness.
    Haw C; Stubbs J
    J Intellect Disabil Res; 2005 Nov; 49(Pt 11):858-64. PubMed ID: 16207284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Off-label use of drugs in pain medicine and palliative care: an algorithm for the assessment of its safe and legal prescription.
    Verhagen CC; Niezink AG; Engels YY; Hekster YY; Doornebal JJ; Vissers KC
    Pain Pract; 2008; 8(3):157-63. PubMed ID: 18373512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescribing of sulfasalazine, azathioprine and methotrexate round pregnancy--a descriptive study.
    Vroom F; van Roon EN; van den Berg PB; Brouwers JR; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):52-61. PubMed ID: 17948319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. U.S. physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey.
    Chen DT; Wynia MK; Moloney RM; Alexander GC
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1094-100. PubMed ID: 19697444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uses of drugs not described in the package insert (off-label uses).
    Committee on Drugs. American Academy of Pediatrics
    Pediatrics; 2002 Jul; 110(1 Pt 1):181-3. PubMed ID: 12093968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Off-label prescribing of drugs in specialty headache practice.
    Loder EW; Biondi DM
    Headache; 2004; 44(7):636-41. PubMed ID: 15209684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Off-label prescriptions: how to identify them, frame them, announce them and monitor them in practice?
    Le Jeunne C; Billon N; Dandon A; ; Berdaï D; Adgibi Y; Bergmann JF; Bordet R; Carpentier A; Cohn E; Courcier S; Girault D; Goni S; Jolliet P; Liard F; Prot-Labarthe S; Simon T; Vernotte C; Westerloppe J
    Therapie; 2013; 68(4):225-39. PubMed ID: 23981260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prescription drugs and the elderly: results of the Argento study].
    Pizzuti R; Caffari B; Binkin N;
    Ig Sanita Pubbl; 2006; 62(1):11-26. PubMed ID: 17206165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.